Eric Warren - 21 Jun 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
21 Jun 2023
Transactions value $
-$894
Form type
4
Filing time
22 Jun 2023, 16:45:17 UTC
Previous filing
18 May 2023
Next filing
20 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$894 -603 -0.86% $1.48 69.4K 21 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.